结果87例乙肝性肝硬化患者中胆囊炎胆石症患者共占71.2%，94例胆囊炎胆石症患者乙肝病毒感染率达57.4%。
Results There were 71.2%of cholecystitis cholelithiasis in group of hepatitis B liver cirrhosis cases, 94 cases of cholecystitis cholelithiasis in patients with HBV infection rate of 57.4%.
结论隐匿型乙肝感染可能是部分隐源性肝癌、肝硬化的病因。
Conclusion The occult infection of HBV may be an important cause of cryptogenic cirrhosis and liver cancer.
目的研究乙肝肝硬化门静脉高压性胃病的组织病理学变化。
Objective To study the histopathological features of cirrhotic portal hypertension gastropathy resulting from hepatitis B.
目的研究中药制剂达美施乙肝三号治疗乙肝后肝纤维化、肝硬化的治疗效果及安全性。
Objective To evaluate the efficiency and safety of "TINMAX" HB-3 Herbal Compound (cpd) in treatment of hepatofibrosis and cirrhosis post chronic hepatitis B.
目的研究中药制剂达美施乙肝三号治疗乙肝后肝纤维化、肝硬化的治疗效果及安全性。
Objective To evaluate the efficiency and safety of "TINMAX" HB-3 Herbal Compound (cpd) in treatment of hepatofibrosis and cirrhosis post chronic hepatitis B.
应用推荐